Nanotherapeutics Receives U.S. Department of Defense Contract for Clinical Trial to Treat Dehisced Wounds with NanoDOX(R) Hydrogel
11/3/2010 10:01:22 AM
More...
|
Nanotherapeutics Submits Investigational New Drug Application to FDA for Clinical Testing of Oral Drug to Treat Radiation Exposure
8/30/2010 9:34:31 AM
More...
|
Nanotherapeutics Acquires Two Late Stage Clinical Programs for Alzheimer's Treatment and CDA Disease From Oscient Pharmaceuticals Corporation (OSCI) And EPIX Pharmaceuticals, Inc. (EPIX)
12/16/2009 8:53:27 AM
More...
|
Nanotherapeutics Acquires Assets of DelSite, Inc.
10/1/2009 8:55:15 AM
More...
|
Nanotherapeutics Awarded $30.9 Million National Institute of Allergy And Infectious Diseases (NIAID) Contract to Develop Inhaled Antiviral for Prophylaxis and Treatment of Smallpox
8/24/2009 8:41:54 AM
More...
|
Nanotherapeutics Announces NanoBUP(TM) Capsule for Treating Opiate Addiction Demonstrated Bioavailability and Safety in Phase Ia Clinical Trial
8/6/2009 10:47:41 AM
More...
|
Nanotherapeutics Advances Two Clinical Programs
3/11/2009 10:36:21 AM
More...
|
Nanotherapeutics Files Investigational New Drug Application for NanoDOX(TM) Hydrogel to Treat Lower Extremity Diabetic Ulcers
9/4/2008 8:40:43 AM
More...
|
Nanotherapeutics Announces Election of New Directors and Officers
1/31/2008 8:44:42 AM
More...
|
Nanotherapeutics Awarded $20 Million National Institute on Drug Abuse (NIDA)/BARDA Contract to Develop Inhaled Gentamicin for Treatment of Aerosol Exposure to Bioterrorism Agents
10/11/2007 9:41:02 AM
More...
|
|